LRRK2 and Parkinson disease: While pathogenic mutations in LRRK2 and GBA account for a fraction of familial and sporadic PD cases, many risk-associated variants lie within noncoding regions, modulating gene expression through subtle regulatory mechanisms (Ito and Utsunomiya-Tate, 2023).